Advancing drug development in pediatric oncology

Advancing drug development in pediatric oncology, a focus on ...

With the development of novel treatment therapies as well as evolving and innovative approaches to conduct clinical trials, the landscape of ...

Advancing drug development in pediatric oncology, a focus on ...

The iMATRIX platform is a mechanism-of-action (MOA)–based phase 1/2 trial framework for concurrently studying multiple molecules across a range of relevant ...

Accelerating Drug Development in Pediatric Oncology With the ...

In oncology, pediatric drug development has additional challenges that have historically delayed availability of safe and effective medicines for children. In ...

Advancing Pediatric Cancer Research and Drug Development ...

Advancing Pediatric Cancer Research and Drug Development Through Multistakeholder Collaboration ... require pediatric clinical trials for new oncology drugs.

Accelerating Cancer Drug Development for Children and Adolescents

Childhood Tumors are Fundamentally Different from Malignancies in Adults · FDA Approvals for Pediatric Cancer Drugs in 2022 · Future ...

ACCELERATE Paediatric Strategy Forums: an advance for ...

The landscape of anticancer drug development in children is changing with the implementation of a science-driven, mechanism-of-action-based approach that ...

Accelerating the Global Development of Pediatric Cancer Drugs

Cancer drug development for children extensively leverages adult drug discovery and development. The demonstration of effectiveness and approval ...

Pediatric oncology drug development and dosage optimization

A framework for better dosage finding through advanced clinical trial design and innovative quantitative approaches for pediatric oncology populations, for ...

Advancing drug development in pediatric oncology, a focus on ...

Advancing drug development in pediatric oncology, a focus on cancer biology and targeted therapies: iMATRIX platform. Uguen, Marianne; Hilton, Magalie; ...

Advancing Pediatric Cancer Research and Drug Development ...

Annette Bakker, PhD. Children's Tumor Foundation. Caitlyn Barrett, PhD. Milken Institute. Upal Basu Roy, MPH, PhD. LUNGevity Foundation.

Sponsored Webcast: Optimizing Pediatric Oncology Drug ... - RAPS

By understanding and implementing strategic solutions to address challenges in these key areas, we can accelerate the development of essential oncology ...

FDARA's Impact on Pediatric Cancer Drugs: Insights From May 2024 ...

The May 2024 ODAC meeting discussed FDARA's impact on pediatric cancer drug development, emphasizing international collaboration and early regulatory ...

Fostering Pediatric Oncology Drug Development - Certara

In addition, pediatric cancer drug development presents multiple challenges. Pediatric cancers include multiple rare tumor types. A substantial proportion of ...

ACCELERATE Paediatric Strategy Forums - The Lancet

The landscape of anticancer drug development in children is changing with the implementation of a science-driven, mechanism-of-action-based approach.

Pediatric Cancer Drug Development - Charles River Laboratories

Pediatric tumors have different genomic drivers and phenotypes than adult tumors, requiring unique preclinical models. Finding the right preclinical platform ...

May 22, 2024 Pediatric Oncology Subcommittee of the ... - YouTube

U.S. Food and Drug Administration · Understanding Drug Recalls with Dr. · Advancing Generic Drug Development: Translating Science to Approval 2024 ...

A well-meaning FDA policy is a threat to pediatric cancer treatment

Project Optimus adds unnecessary complexity, risk, and costs, and at a point that is way too early to inform efficient drug development for ...

Pediatric Oncology - FDA

The mission of the Oncology Center of Excellence Pediatric Oncology Program is to promote the development of safe and effective new drugs and biologics to ...

For the Children: Advancing the Cause of Pediatric Cancer Research

Importantly, this will place pediatric drug development centrally in drug development plans, and will require every program to consider ...

Accelerating Pediatric Drug Development

The first session covered challenges and opportunities in pediatric oncology drug development. Panelists presented and discussed the attributes of on-going ...